Who should not take Survodutide?
Documented caution flags for Survodutide include mTC / MEN-2 history and pancreatitis history. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Survodutide is limited.
Documented caution flags for Survodutide
- MTC / MEN-2 history
- Pancreatitis history
- Pregnancy / nursing
- Severe cardiovascular disease
Reported side effects to weigh
- Nausea (especially titration steps)
- Diarrhea or constipation
- Mild fatigue
- Slightly elevated heart rate (glucagon effect)
References
- Survodutide for treatment of obesity, Phase 2 trial — le Roux CW et al., Lancet Diabetes Endocrinol, 2024
- A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis — Sanyal et al., N Engl J Med, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Survodutide
Last updated 2026-06-15.